期刊文献+

获得性纯红细胞再生障碍性贫血的细胞免疫发病机制的研究进展 被引量:7

The Advance of Research on Pathogenesis of Acquired Pure Red Cell Aplastic Anemia Caused by Cellular Immune Abnormalities
下载PDF
导出
摘要 纯红细胞再生障碍性贫血是以骨髓单纯红系造血衰竭或紊乱为特征的一组异质性疾病 ,分为先天性和获得性两类。细胞免疫介导的红系造血损伤可能是获得性纯红细胞再生障碍性贫血的主要发病机制。本文就近年来关于获得性纯红细胞再生障碍性贫血的T细胞异常、T细胞亚群改变。 Pure red cell aplastic anemia (PRCA) is a group of heterogeneous disorders characterized by erythropoiesis failure or disorder of bone marrow function. PRCA can be classified as congenital and acquired types. The recent researches have shown that cellular immune abnormalities are main reasons to cause PRCA. This review will focus on the focus points: T lymphocytes abnormalities, change of T cell subset phenotypes, abnormality of cellular clonality,and effects of related cytokines in PRCA.
作者 代阳
出处 《中国实验血液学杂志》 CAS CSCD 2003年第1期105-108,共4页 Journal of Experimental Hematology
关键词 纯红细胞再生障碍性贫血 细胞免疫异常 T细胞亚群 细胞因子 pure red cell aplastic anemia cellular immune abnormality T cell subset cytokine
  • 相关文献

参考文献24

  • 1[1]Alter R, Joshi SS, Verdirame JD, et al. Pure red cell aplasia associated with B cell lymphoma: demonstration of bone marrow colony inhibition by serum immunoglobulin. Leuk Res, 1990; 14:279-286
  • 2[2]Murase T. Bilineage hematopoietic inhibitor and T lymphocyte dysfunction in a patient with pure red cell aplasia, myasthenia gravis and thymoma. Exp Hematol, 1993; 21:451 - 455
  • 3[3]Rosenow EC, Hurley T. Disorders of the thymus. A review. Arch Intern Med, 1984; 144:763- 770
  • 4[4]Totterman TH, Bengtsson M, et al. Treatment of pure red cell aplasia with ciclosporine: suppression of activated T suppressor/cytotoxic and NK-like cells in marrow and blood correlates with haematological response. Eur J Haematol, 1988; 41: 204 - 211
  • 5[5]Kaito K, Masuoka H, Kobayashi M, et al. Cyclosporin for pure red cell aplasia caused rapid improvement of anemia and increase of CD4/CD8 ratio. Rinsho Ketsueki, 1993; 34:159- 164
  • 6[6]Yamada O, Mizoguchi H, Oshimi K. Cyclophosphamide therapy for pure red cell aplasia asociated with granular lymphocyte-proliferative disorders. Br J Haematol, 1997; 97:392 - 399
  • 7[7]Kwong YL, Wong KF. Association of pure red cell aplasia with T large granlular lymphocyte leukemia. J Clin Pathol, 1998; 51: 672- 675
  • 8[8]Dincol G, Aktan M, Nalcaci M, et al. Clonality of acquired primary pure red cell aplasia: effectivess of antithymocyte globulin. Leuk lymphoma, 2001; 42:1413 - 1417
  • 9[9]Masuda M, Arai Y, Okamura T, et al. Pure red cell aplasia with thymoma: evidence of T-cell clonal disorder. Am J Hematol, 1997;54: 324 - 328
  • 10[10]Masauzi N, Tanaka J, Watanabe M, et al. Primary Waldenstrom's macroglobulinemia associated with pure red cell aplasia in which Ts/Tc lymphocytes inhibiting erythroid precursors were detected. Rinsho Ketsueki, 1993; 34:355 - 361

同被引文献44

  • 1孟荷,贾真,于兰君.应用重组人红细胞生成素致纯红再障7例临床分析[J].中原医刊,2005,32(8):31-31. 被引量:7
  • 2马劼,赖永榕,蔡正文,彭志刚,杨杰,邓东红,赵卫华,农月初.ABO血型不合的同胞异基因外周血干细胞移植[J].中国输血杂志,2006,19(2):107-110. 被引量:15
  • 3孙阳.抗促红细胞生成素抗体介导的纯红再障[J].中国血液净化,2006,5(8):410-412. 被引量:8
  • 4许文荣,王建中.临床血液学与捡验(第4版)[M].北京:人民卫生出版社,2007:179.
  • 5Lee JH, Lee KH, Kim S, et al. Anti A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible aliogeneic bone marrow transplantation. Bone Marrow Transplant, 2000, 25: 179.
  • 6Bar BM,Van Dijk Ba, Schattesberg A, et al. Erythrocyte repopulation after major ABO incompatible transplantation with lymphocytepleted bone marrow. Bone Marrow Transplant, 1995,16 :793.
  • 7Charies D, Bolan, Susan F. Leitman, Linda M. Griffith, et al.Delayed donor red cell chimerism and pure red cell aplasia following major ABO-ineompatible nonmyeloablative hematopoietic stem cell transplantation. Blood, 2001,15: 1687.
  • 8Ohtm S, Yokoyama H, Ise T, et al. Apheresis therapy for prolonged red ceil aplasla after major ABO-mismateh bone marrow transplantation. Intern Med, 1997, 36:487.
  • 9M Musso, F Porretto, A Crescimanno,et al. Donor lymphocyte infusions for refractory pure red cell aplasia relapsing after both antilogous and nonmyeloablative allogeneic peripheral stem cell transplantation. Bone Marrow Transplant, 2004,33: 769.
  • 10Federica Sord MD,Silvia De Matteis MID, Nicola Piccirilio MD,et al. Rituximab for pure red cell aplasia after ABO-mismatched allogeneic peripheral blood progenitor cell transplantation.Transfusion, 2005,45 : 643.

引证文献7

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部